Citable company snapshot
CVS Health's latest SEC-sourced 2026-03-31 period shows $100.43B in revenue and $2.94B in net income.
| Metric | Latest period | Latest value | Prior value | YoY |
|---|---|---|---|---|
| xbrl:Revenues | Mar 31, 2026 | $100.43B | $105.69B | -5.0% |
| xbrl:GrossProfit | Sep 30, 2018 | $7.33B | $7.20B | +1.8% |
| xbrl:OperatingIncomeLoss | Mar 31, 2026 | $4.68B | $2.11B | +121.6% |
| xbrl:NetIncomeLoss | Mar 31, 2026 | $2.94B | $2.94B | 0.0% |
| xbrl:NetCashProvidedByUsedInOperatingActivities | Mar 31, 2026 | $4.25B | $3.39B | +25.3% |
| Free Cash Flow (computed) | Mar 31, 2026 | $3.40B | $2.61B | +30.5% |
Source: SEC EDGAR XBRL; period Mar 31, 2026; filed May 6, 2026; accession 0000064803-26-000052.
Continue research
Follow same-sector companies and source explainers connected to the financials view.
A factual guide to free cash flow — how it is built from the cash flow statement, why presentations differ, and how Aerarium Research shows the source.
A factual guide to working capital, current assets, current liabilities, and the operating cash cycle.
A factual guide to stock-based compensation, how it appears in company filings, and why it connects cash flow to share count.
A factual guide to goodwill, intangible assets, acquisitions, and impairment charges in company financial statements.
